SDHB Mouse mAbK10627
无载体, 无叠氮钠, 已验证, 高性能, 见COA
抗体类
共15,266件商品alpha Tubulin Mouse mAbK10628
ExactAb™, Validated, Carrier Free, Azide Free, High performance, 0.5 mg/mL
Recombinant CD20 Antibody (FITC)K10629
重组, 已验证, 无叠氮钠, Ex:498nm, Em:517nm, 0.1mg/mL; 10uL/Test
Recombinant CD20 Antibody (APC)K10630
重组, 已验证, 无叠氮钠, Ex:650nm, Em:660nm, 0.02mg/mL; 10uL/Test
Recombinant CD20 Antibody (Biotin)K10631
重组, 已验证, 无叠氮钠, 无载体, 1.0 mg/mL
Recombinant CD20 Antibody (PE)K10632
重组, 已验证, 无叠氮钠, Ex:565nm, Em:575nm, 0.05mg/mL; 10uL/Test
Recombinant CD20 Antibody (PerCP)K10633
重组, 已验证, 无叠氮钠, Ex:482nm, Em:675nm, 0.05mg/mL; 10uL /Test
Cofilin Mouse mAbK10634
ExactAb™, Validated, Carrier Free, Azide Free, High performance, 1.0 mg/mL
Vinculin Mouse mAbK10635
无载体, 无叠氮钠, 已验证, 高性能, 见COA
Tiragolumab (anti-TIGIT)K10636 · CAS 1918185-84-8
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Omalizumab (anti-IgE)K10637 · CAS 242138-07-4
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Evinacumab (anti-ANGPTL3)K10638 · CAS 1446419-85-7
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Necitumumab (anti-EGFR)K10639 · CAS 906805-06-9
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Alirocumab (anti-PCSK9)K10640 · CAS 1245916-14-6
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Risankizumab (anti-IL-23)K10641 · CAS 1612838-76-2
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Vedolizumab (anti-α4β7-integrin)K10642 · CAS 943609-66-3
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Elotuzumab (anti-SLAMF7)K10643 · CAS 915296-00-3
无载体, 重组, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Emapalumab (anti-IFNγ)K10644 · CAS 1709815-23-5
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Brodalumab (anti-IL17RA)K10645 · CAS 1174395-19-7
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Pamrevlumab (anti-CTGF)K10646 · CAS 946415-13-0
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Isatuximab (anti-CD38)K10647 · CAS 1461640-62-9
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Siltuximab (anti-IL-6)K10648 · CAS 541502-14-1
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Spartalizumab (anti-PD-1)K10649 · CAS 1935694-88-4
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Tremelimumab (anti-CTLA-4)K10650 · CAS 745013-59-6
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
第 27 / 637 页